)
Edge10 Jul 2026
Inside Take-Two: The Grand Anticipation
The story of how Take-Two Interactive built the empire behind Grand Theft Auto, Red Dead Redemption, and one of gaming's largest mobile portfolios.
VolitionRX
VolitionRX (VNRX) investor relations material
VolitionRX Registration filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Registration filing summary10 Jul, 2026
Company overview and business model
Multi-national epigenetics company developing blood tests for early detection and monitoring of diseases like cancer and sepsis.
Product portfolio includes Nu.Q® Vet (for companion animals), Nu.Q® NETS (for NETosis-related diseases), Nu.Q® Discover, and cancer-focused diagnostics.
Operations span Belgium, California, London, and Nevada, with approximately 60 employees.
Collaborates with academic, clinical, and industry partners globally.
Financial performance and metrics
Issued secured convertible notes totaling $9.9 million in 2025 and 2026, with associated warrants.
Imposed additional 10% penalty on outstanding principal due to market capitalization covenant breach in May 2026.
May face liquidity challenges if unable to generate sufficient cash flow to service debt.
Use of proceeds and capital allocation
Will not receive any proceeds from the sale of shares by the selling stockholder; all proceeds go to the selling stockholder.
Responsible for registration expenses, excluding brokerage commissions.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from VolitionRX
- Nu.Q blood tests enable rapid, cost-effective cancer detection and monitoring worldwide.VNRX
Study update3 Jul 2026 - Shareholders will vote on directors, auditor, compensation, share reduction, and a new incentive plan.VNRXProxy filing2 Jun 2026
- Q1 2026 revenue reached $1.0M, but net loss increased amid clinical and licensing progress.VNRXQ1 202615 May 2026
- Major licensing deals, global launches, and clinical milestones drive growth in cancer and sepsis diagnostics.VNRXInvestor presentation15 May 2026
- Board recommends approval of all proposals, including share reduction and new incentive plan.VNRXProxy filing13 May 2026
- Revenue up 40% to $1.7M, with clinical milestones and new funding amid going concern risk.VNRXQ4 20251 Apr 2026
- Licensing-driven diagnostics platform targets multi-billion dollar markets with scalable, low-cost tests.VNRXCorporate presentation1 Apr 2026
- Shareholders to vote on major share issuance and reverse stock split to support compliance and flexibility.VNRXProxy Filing11 Feb 2026
- Registration enables resale of 17.97M shares, raising dilution and financial risk concerns.VNRXRegistration Filing9 Feb 2026
Next VolitionRX earnings date
Q2 202614 Aug, 2026
VolitionRX
Next VolitionRX earnings date
Q2 202614 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage